Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - ProPhase Labs, Inc. | v336477_8k.htm |
Exhibit 99.1
Transcript of Segment of Ted Karkus Interview Aired on Fox Business on February 25, 2013
| Host | Ok, there was a 27% rise in the incidents of cold and flu in January. |
| Ted Karkus | Correct. |
| Host | In January, the category for cold and flu remedies, over the counter sales, went up 37%. |
| Ted Karkus | 33%. |
| Host | 33%. |
| Ted Karkus | Correct. |
| Host | So how much are your sales up? |
| Ted Karkus | Okay, the other variables are, are you advertising and are you introducing new products? For the past two years, we have been advertising more and introducing more products. So Cold-EEZE cold remedy sales have actually been increasing faster than the category and faster than the incidents of upper respiratory illness. |
| Host | So you are a publicly traded company and you cannot tell me precisely how much sales of Cold-EEZE went up in January, but you can tell me that you went up more than the industry average for that kind of remedy, 33%. |
| Ted Karkus | Correct. The category was actually down in 2011, we were up 20%. In 2012 the category was down in the first nine months of the year, we were up 27%. That is what we reported. In the fourth quarter of 2012, the numbers are up even more, so you can expect that our numbers are up even more. |